See more : Commonwealth Bank of Australia (CBA.SW) Income Statement Analysis – Financial Results
Complete financial analysis of IMCD N.V. (IMCDY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of IMCD N.V., a leading company in the Chemicals industry within the Basic Materials sector.
- Chrysos Corporation Limited (C79.AX) Income Statement Analysis – Financial Results
- Horizon Technology Finance Corporation (HRZN) Income Statement Analysis – Financial Results
- Body One SA (MLONE.PA) Income Statement Analysis – Financial Results
- Cementir Holding N.V. (CEM.MI) Income Statement Analysis – Financial Results
- Parkway Corporate Limited (PWN.AX) Income Statement Analysis – Financial Results
IMCD N.V. (IMCDY)
About IMCD N.V.
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers enzymes, surfactants, biocides, chelates, rheology modifiers, solubilisers, silicones, solvents, and functional additives; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. It also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.46B | 4.60B | 3.44B | 2.77B | 2.69B | 2.38B | 1.91B | 1.71B | 1.53B | 1.37B | 1.24B | 1.47B |
| Cost of Revenue | 3.32B | 4.04B | 3.07B | 2.53B | 2.46B | 2.15B | 1.74B | 1.56B | 1.40B | 1.07B | 972.08M | 1.16B |
| Gross Profit | 1.14B | 565.69M | 362.30M | 248.15M | 231.55M | 228.47M | 168.01M | 151.85M | 130.29M | 294.92M | 269.68M | 313.69M |
| Gross Profit Ratio | 25.61% | 12.29% | 10.55% | 8.94% | 8.61% | 9.60% | 8.81% | 8.86% | 8.52% | 21.59% | 21.72% | 21.31% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 27.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 125.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 152.71M | 103.33M | 65.32M | 59.12M | 65.30M | 71.11M | 42.85M | 36.70M | 33.10M | 142.31M | 135.53M | 158.67M |
| Other Expenses | 561.67M | -11.50M | -4.40M | -3.70M | 0.00 | 0.00 | 0.00 | 0.00 | -11.63M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 714.38M | 114.83M | 69.72M | 62.82M | 65.30M | 71.11M | 42.85M | 36.70M | 44.73M | 236.79M | 198.27M | 225.34M |
| Cost & Expenses | 4.03B | 4.15B | 3.14B | 2.59B | 2.52B | 2.22B | 1.78B | 1.60B | 1.44B | 1.31B | 1.17B | 1.38B |
| Interest Income | 1.76M | 2.84M | 1.80M | 639.00K | 695.00K | 26.06M | 15.49M | 12.62M | 12.44M | 40.36M | 87.06M | 94.31M |
| Interest Expense | 50.00M | 27.30M | 18.13M | 20.45M | 23.78M | 23.70M | 13.63M | 12.59M | 10.95M | 55.21M | 63.95M | 72.02M |
| Depreciation & Amortization | 114.22M | 111.49M | 92.86M | 73.16M | 66.16M | 42.67M | 38.60M | 36.32M | 29.89M | 23.30M | 21.86M | 24.75M |
| EBITDA | 567.30M | 574.96M | 395.23M | 258.62M | 239.89M | 207.11M | 165.86M | 151.69M | 131.60M | 112.89M | 98.87M | 121.32M |
| EBITDA Ratio | 12.71% | 12.22% | 11.22% | 9.32% | 8.64% | 8.41% | 8.59% | 8.83% | 7.55% | 8.27% | 7.96% | 8.24% |
| Operating Income | 428.52M | 450.85M | 292.59M | 185.34M | 166.25M | 157.36M | 125.16M | 115.15M | 85.55M | 89.59M | 77.01M | 96.57M |
| Operating Income Ratio | 9.60% | 9.80% | 8.52% | 6.68% | 6.18% | 6.61% | 6.56% | 6.72% | 5.59% | 6.56% | 6.20% | 6.56% |
| Total Other Income/Expenses | -25.45M | -25.88M | -21.64M | -25.81M | -26.71M | -23.40M | -15.18M | -12.75M | -7.69M | -57.57M | -65.18M | -101.08M |
| Income Before Tax | 403.08M | 435.85M | 283.80M | 164.62M | 149.24M | 139.20M | 110.05M | 94.75M | 77.87M | 24.78M | 8.19M | -5.95M |
| Income Before Tax Ratio | 9.03% | 9.47% | 8.26% | 5.93% | 5.55% | 5.85% | 5.77% | 5.53% | 5.09% | 1.81% | 0.66% | -0.40% |
| Income Tax Expense | 110.85M | 122.85M | 76.59M | 44.45M | 41.35M | 39.13M | 32.72M | 21.80M | 16.02M | 4.88M | 13.58M | 17.54M |
| Net Income | 292.27M | 313.08M | 207.28M | 120.13M | 108.01M | 100.06M | 77.26M | 72.96M | 61.85M | 19.91M | -5.39M | -23.50M |
| Net Income Ratio | 6.55% | 6.80% | 6.03% | 4.33% | 4.02% | 4.21% | 4.05% | 4.26% | 4.04% | 1.46% | -0.43% | -1.60% |
| EPS | 5.13 | 5.50 | 3.64 | 2.24 | 2.06 | 1.91 | 1.47 | 1.39 | 1.20 | 0.79 | -8.62 | -37.59 |
| EPS Diluted | 5.13 | 5.49 | 3.63 | 2.23 | 2.06 | 1.91 | 1.47 | 1.39 | 1.20 | 0.79 | -8.62 | -37.59 |
| Weighted Avg Shares Out | 56.97M | 56.93M | 56.94M | 53.75M | 52.48M | 52.44M | 52.42M | 52.48M | 51.61M | 25.20M | 625.00K | 625.00K |
| Weighted Avg Shares Out (Dil) | 57.00M | 57.03M | 57.06M | 53.89M | 52.48M | 52.44M | 52.42M | 52.55M | 51.61M | 25.20M | 625.00K | 625.00K |
Source: https://incomestatements.info
Category: Stock Reports